Phagocytosis, the process where specialised cells of the immune system kill and decompose microorganisms (e.g. extracellular bacteria), is fundamental to innate non-specific human immunity. Polymorphonuclear leukocytes (neutrophilic granulocytes), macrophages and dendritic cells are the effector cells in the process of phagocytosis.
Phagocytosis is preceded by chemotactic migration of the phagocytes (mainly neutrophilic granulocytes) into the site of inflammation. Then the foreign particles are recognized, ingested (forming phagosome and phagolysosome), and finally destructed by oxygen-independent and oxygen-dependent mechanisms. The latter ones (the “oxidative burst”) involve a release of reactive oxygen radicals, hydrogen peroxide, hydroxyl radical, and hypochlorite. In this process the key enzymes are the NADPH oxidase and myeloperoxidase, whose malfunction leads to impaired bactericidal mechanisms. PHAGO
The FagoFlowEx Kit is intended for examination of phagocytic activity of neutrophil granulocytes by measuring the respiratory (oxidative) burst after their stimulation with E. coli bacteria in human heparinized whole blood using flow cytometry.
Histogram 1 - overlay: Healthy donor without defect of respiratory burst, (SI = 98)
Histogram 2 - overlay: Patient with MPO deficiency, (SI = 11)
Histogram 3 - overlay: Male patient with CGD, (SI = 16)
Histogram 4 - overlay: Female carrying X-linked mutation of the NADPH oxidase gene.
Two granulocyte subpopulations differ in respiratory burst intensity, (SIlow = 13.9, SIhigh = 125).
IngoFlowEx Kit is designed for quantification of phagocytic activity of human granulocytes and monocytes by measuring the ingestion of fluorescently labeled E. coli bacteria in human heparinized whole blood using flow cytometry.
Gates for granulocytes and monocytes (left) and overlay of histograms of granulocyte and monocyte subpopulation (right).
Recently we have informed you about comparison of four anti-human CD16 clones specificity. Now we present another interesting CD16-related data.
Today we introduce a newly added mouse monoclonal antibody 11G2, which detects CD156c.